Region-specific effects of a tyrosine-free amino acid mixture on amphetamine-induced changes in BOLD fMRI signal in the rat brain

Synapse

Volumn 61, Issue 11, 2007, Pages 925-932

  Preece, Mark A ^a   Sibson, Nicola R ^a   Raley, Josephine M ^a   Blamire, Andrew ^b   Styles, Peter ^c   Sharp, Trevor ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Amphetamine; Dopamine; fMRI; Tyrosine depletion

Indexed keywords

AMINO ACID; AMPHETAMINE; HALOTHANE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE;

AMINO ACID DEPLETION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD OXYGENATION LEVEL DEPENDENT FUNCTIONAL MAGNETIC RESONANCE IMAGING; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; DOPAMINE METABOLISM; DOPAMINE RELEASE; DRUG ABUSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; IN VIVO STUDY; MALE; MOTOR CORTEX; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; THALAMUS;

AMPHETAMINE; ANIMALS; BRAIN; BRAIN MAPPING; DOPAMINE UPTAKE INHIBITORS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TYROSINE;

EID: 34648843278     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20442     Document Type: Article

References (34)

1. Biggio G, Porceddu ML, Gessa GL. 1976. Decrease of homovanillic, dihydroxyphenylacetic acid and cyclic-adenosine-3′,5′-monophosphate content in the rat caudate nucleus induced by the acute administration of an amino acid mixture lacking tyrosine and phenylalanine. J Neurochem 26:1253-1255.
2. Blamire AM, Rothman DL, Nixon T. 1996. Dynamic shim updating: A new approach towards optimized whole brain shimming. Magn Reson Med 36:159-165.
3. Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM. 1999. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci USA 96:12079-12084.
4. Chen YC, Galpern WR, Brownell AL, Matthews RT, Bogdanov M, Isacson O, Keltner JR, Beal MF, Rosen BR, Jenkins BG. 1997. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data. Magn Reson Med 38: 389-398.
5. Chen YC, Choi JK, Andersen SL, Rosen BR, Jenkins BG. 2005. Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging. Psychopharmacology 180:705-715.
6. de Graaf RA, Brown PB, McIntyre S, Rothman DL, Nixon TW. 2004. Dynamic shim updating (DSU) for multislice signal acquisition. Magn Reson Med 49:409-416.
7. Dixon AL, Prior M, Morris PM, Shah YB, Joseph MH, Young AM. 2005. Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology 48: 236-245.
8. Edvinsson L, McCulloch J, Sharkey J. 1985. Vasomotor responses of cerebral arterioles in situ to putative dopamine receptor agonists. Br J Pharmacol 85:403-410.
9. Fernstrom JD. 1983. Role of precursor availability in control of monoamine biosynthesis in brain. Physiol Rev 63:484-546.
10. Fox PT, Raichle ME. 1986, Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci USA 83:1140-1144.
11. Fox PT, Raichle ME, Mintun MA, Dence C. 1988. Nonoxidative glucose consumption during focal physiologic neural activity. Science 241:462-464.
12. Harel N, Lee SP, Nagaoka T, Kim DS, Kim SG. 2002. Origin of negative blood oxygenation level-dependent fMRI signals. J Cereb Blood Flow Metab 22:908-917.
13. Houston GC, Papadakis NG, Carpenter TA, Hall LD, Mukherjee B, James MF, Huang CL. 2001. Mapping of brain activation in response to pharmacological agents using fMRI in the rat. Magn Reson Imaging 19:905-919.
14. Kuczenski R, Segal DS, Cho AK, Melega W. 1995. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioural responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 15:1308-1317.
15. Le Masurier M, Houston G, Cowen P, Grasby P, Sharp T, Hume S. 2004a. Tyrosine-free amino acid mixture attenuates amphetamine-induced displacement of [11C]raclopride in striatum in vivo: A rat PET study. Synapse 51:151-157.
16. Le Masurier M, Cowen PJ, Sharp T. 2004b. Fos immunocytochemical studies on the neuroanatomical sites of action of acute tyrosine depletion in the rat brain. Psychopharmacology (Berl) 171: 435-440.
17. Le Masurier M, Oldenzeil W, Lehman C, Cowen P, Sharp T. 2006. Effect of acute tyrosine depletion in using a branched chain amino-acid mixture on dopamine neurotransmission in the rat brain. Neuropsychopharmacology 31:310-317.
18. Leyton M, Daher A, Boileau I, Casy K, Baker GB, Diksic M, et al. 2004. Decreasing amphtamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men. Neuropsychopharmacology 29:427-432.
19. McLean A, Rubinsztein JS, Robbins TW, Sahakian BJ. 2004. The effects of tyrosine depletion in normal healthy volunteers: Implications for unipolar depression. Psychopharmacology (Berl) 171:286-97.
20. McTavish SF, McPherson MH, Sharp T, Cowen PJ. 1999a. Attenuation of some subjective effects of amphetamine following tyrosine depletion. J Psychopharmacol 13:144-147.
21. McTavish SF, Cowen PJ, Sharp T. 1999b. Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology 141:182-188.
22. McTavish SF, Callado L, Cowen PJ, Sharp T. 1999c. Comparison of the effects of α-methyl-p-tyrosine and a tyrosine-free amino acid load on extracellular noradrenaline in the rat hippocampus in vivo. J. Psychopharmacology 13:379-384.
23. McTavish SF, Raumann B, Cowen PJ, Sharp T. 2001a. Tyrosine depletion attenuates the behavioural stimulant effects of amphetamine and cocaine in rats. Eur J Pharmacol 424:115-119.
24. McTavish SF, McPherson MH, Harmer CJ, Clark L, Sharp T, Goodwin GM, Cowen PJ. 2001b. Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry 179:356-60.
25. Moja EA, Restani P, Corsini E, Stacchezzini MC, Assereto R, Galli CL. 1991. Cycloheximide blocks the fall of plasma and tissue tryptophan levels after tryptophan-free amino acid mixtures. Life Sci 49:1121-1128.
26. 11C]raclopride study. Am J Psychiatry 160:1887-1889.
27. Paxinos G, Watson C. 1986. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press.
28. Palmour RM, Ervin FR, Baker GB, Young SN. 1998. An amino acid mixture deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine metabolites and alcohol consumption in vervet monkeys. Psychopharmacology 136:1-7.
29. Preece M, Mukherjee B, Huang CL, Hall LD, Leslie RA, James MF. 2001. Detection of pharmacologically mediated changes in cerebral activity by functional magnetic resonance imaging: The effects of sulpiride in the brain of the anaesthetised rat. Brain Res 916:107-114.
30. Raichle ME. 1998. Behind the scenes of functional brain imaging: A historical and physiological perspective. Proc Natl Acad Sci USA 95:765-772.
31. Seeman P, Kapur S. 2003. Anesthetics inhibit high-affinity states of dopamine D2 and other G-linked receptors. Synapse 50:35-40.
32. Shah YB, Prior MJ, Dixon AL, Morris PG, Marsden CA. 2004. Detection of cannabinoid agonist evoked increase in BOLD contrast in rats using functional magnetic resonance imaging. Neuropharmacology 46:379-387.
33. Vollm BA, de Araujo IE, Cowen PJ, Rolls ET, Kringelbach ML, Smith KA, et al. 2004. Methamphetamine activates reward circuitry in drug naive human subjects. Neuropsychopharmacology 29:1715-1722.
34. Woolsey TA, Rovainen CM, Cox SB, Henegar MH, Liang GE, Liu D, et al. 1996. Neuronal units linked to microvascular modules in cerebral cortex: Response elements for imaging the brain. Cereb Cortex 6:647-660.